Fig. 4From: Clinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenzaHow often do you prescribe neuraminidase inhibitors in each of the following groups of hospitalised adults when influenza infection is confirmed (i.e. influenza test result is positive)?Legend: PNA – pneumonia, CLD - Exacerbation of chronic lung disease (e.g. COPD, asthma), LRTI – non-pneumonic lower respiratory tract infection, Other – other acute medical illnesses e.g. cardiac failureBack to article page